Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3571 to 3585 of 8224 results

  1. Making decisions using NICE guidelines

    People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.

  2. How we develop NICE guidelines

    The guidance development timeline

  3. About NICE guidelines

    NICE guidelines are evidence-based recommendations for health and care in England and Wales.

  4. What NICE does

    We're at the forefront of bringing better care to people. We help practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.

  5. Terms and conditions

    Home {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/","name":"Home"}}]}

  6. Content assurance service

    Our content assurance service. Includes what the service offers, how to apply and pricing.

  7. Public task

    Our public task statement, which sets out the mandatory functions which NICE is under a legal duty to perform.

  8. NICE syndication API

    Embed NICE content in your digital products and services with our syndication API.

  9. Use of our content internationally

    Using our content internationally. Includes information on fees and licensing agreements for both AI and non AI requests.

  10. Use of our content for AI purposes

    Using NICE content for AI purposes. Includes complete content, adaptation, contextualisation, translation, selected extracts and the use of our COVID-19 content internationally.

  11. What content is available for reuse?

    Learn more about what NICE content is available for reuse by checking our information asset register.

  12. Is there any content I cannot reuse?

    Learn about situations where you cannot use NICE content.

  13. Reusing our content

    Find out how and where you can reuse NICE's content. Includes use of our content in the UK, use of our content internationally, use of our content for AI purposes, our content assurance process, and our information asset register.

  14. Research to access pathway for investigational drugs for COVID-19 (RAPID C-19)

    RAPID C-19’s role in reviewing potential COVID-19 treatments has now ended because we have moved back to routine commissioning arrangements for these treatments.

  15. Privacy notice

    How we collect and use your personal information, and your rights under data protection legislation.